P1.25. Prevalence of EGFR Mutations in Patients with Resected Stage I-III NSCLC: Results of the Asian Cohort of EARLY-EGFR - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Tu Dao
Meta Tag
Speaker Tu Dao
Topic Early-Stage NSCLC: Changing Paradigms & Outcomes
EGFR mutations
non-small cell lung cancer
Asian population
stage I-III
exon-19 deletions
PD-L1 positive
platinum-based chemotherapy
adjuvant osimertinib treatment
Powered By